This anti-ErbB2/Her2 (Pertuzumab Biosimilar) antibody is a Humanized Monoclonal antibody detecting ErbB2/Her2 (Pertuzumab Biosimilar) in FACS and in vivo. Suitable for Human.
Catalog No. ABIN7200658
Quick Overview for Recombinant ErbB2/Her2 (Pertuzumab Biosimilar) antibody (ABIN7200658)
Target
ErbB2/Her2 (Pertuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This ErbB2/Her2 (Pertuzumab Biosimilar) antibody is un-conjugated
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Grade
Research Grade
Purpose
Pertuzumab Biosimilar, Human HER2 Monoclonal Antibody
Specificity
The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu.
Characteristics
Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
Purification
Protein A or G affinity column
Purity
>95 % by reducing SDS-PAGE
Sterility
0.2 μm filtered
Endotoxin Level
< 1 EU per 1 mg of the protein by the LAL method
Immunogen
The monoclonal antibody pertuzumab biosimilar was produced in the pertuzumab biosimilar CHO stable cell line.
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
Application Notes
ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pertuzumab.
Restrictions
For Research Use only
Format
Liquid
Concentration
> 3 mg/mL
Buffer
PBS, pH 7.4, no stabilizers or preservatives.
Preservative
Without preservative
Storage
4°C,-20 °C
Storage Comment
12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.